Type: Upload file
A research scientist performs gene expression analysis in the Michael Schwartz Lab. Credit: Clare McLean
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
Surgical oncologist Venu G. Pillarisetty talks about why resting before surgery is the worst thing you can do. Dr. Pillarisetty is senior author of study published in PLOS One finds that finds...
It's the question many ask: Is there a safe amount to drink during pregnancy? A new study published in Advances in Pediatric Research suggests the answer is no. Susan Astley Hemingway, professor of...
It's scary to think about, but an infection during pregnancy, whether the flu or a urinary tract infection, appears to increase a child's risk of being diagnosed with depression or autism. ...
Open surgery has long been the convention for treating aortic stenosis, a potentially lethal condition in which a failing aortic valve reduces blood flow from the heart. But TAVR, or transcatheter...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...
The sci-Plex technique holds promise for cell biology research in cancer, infectious diseases, autoimmune disorders, prenatal medicine and many other medical and basic science areas. Results from...
Much is still unknown about the virus that causes COVID-19. Dr. Kristina Adams Waldorf, professor of obstetrics and gynecology at University of Washington School of Medicine, shifted her lab's focus...